Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Philadelphia, PA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Dallas, TX
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Sacramento, CA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Sacramento, CA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #119
mi
from
Deerfield Beach, FL
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #119
mi
from
Deerfield Beach, FL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Gainesville, FL
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Gainesville, FL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Naples, FL
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Naples, FL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Tampa, FL
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
New Orleans, LA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Chapel Hill, NC
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Durham, NC
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Durham, NC
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Portland, OR
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Providence, RI
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Providence, RI
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Memphis, TN
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Memphis, TN
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Houston, TX
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #215
mi
from
Richmond, VA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #215
mi
from
Richmond, VA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Spokane, WA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Spokane, WA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Berkeley, CA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Berkeley, CA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #170
mi
from
Carlsbad, CA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #170
mi
from
Carlsbad, CA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
San Diego, CA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Jacksonville, FL
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #7138
mi
from
Honolulu, HI
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #7138
mi
from
Honolulu, HI
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Chicago, IL
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #225
mi
from
Fort Wayne, IN
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #225
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #175
mi
from
Fulton, MD
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #175
mi
from
Fulton, MD
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
East Lansing, MI
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
East Lansing, MI
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #164
mi
from
Farmington Hills, MI
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #164
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Grand Rapids, MI
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #177
mi
from
Stratford, NJ
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #177
mi
from
Stratford, NJ
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
New York, NY
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #179
mi
from
Patchogue, NY
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #179
mi
from
Patchogue, NY
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Columbus, OH
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #116
mi
from
Dayton, OH
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #116
mi
from
Dayton, OH
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #182
mi
from
Falls Church, VA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #182
mi
from
Falls Church, VA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #203
mi
from
Fredericton,
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #203
mi
from
Fredericton,
Click here to add this to my saved trials
Oral Guanabenz for Multiple Sclerosis
Phase I Study of Oral Guanabenz for Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Oral Guanabenz for Multiple Sclerosis
Phase I Study of Oral Guanabenz for Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Methylprednisolone Treatment of Friedreich Ataxia
Open-label Pilot Study of Methylprednisolone for the Treatment of Patients With Friedreich Ataxia (FRDA)
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Methylprednisolone Treatment of Friedreich Ataxia
Open-label Pilot Study of Methylprednisolone for the Treatment of Patients With Friedreich Ataxia (FRDA)
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Ormond Beach, FL
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Indianapolis, IN
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Indianapolis, IN
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Raleigh, NC
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Columbus, OH
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Franklin, TN
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Franklin, TN
Click here to add this to my saved trials
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Orem, UT
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Orem, UT
Click here to add this to my saved trials
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Carlsbad, CA
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Carlsbad, CA
Click here to add this to my saved trials
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Pomona, CA
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Pomona, CA
Click here to add this to my saved trials
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Denver, CO
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
mi
from
Grodno,
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
mi
from
Grodno,
Click here to add this to my saved trials
Patient and Caregiver Psychological Functioning Following Neuro-ICU Admission: A Prospective Investigation
A Prospective Study to Investigate Relationships Between Patient and Family Caregiver Distress Following Neuroscience ICU Admission
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Patient and Caregiver Psychological Functioning Following Neuro-ICU Admission: A Prospective Investigation
A Prospective Study to Investigate Relationships Between Patient and Family Caregiver Distress Following Neuroscience ICU Admission
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Phase 1/2 Study in Boys With Duchenne Muscular Dystrophy
A Phase 1/2 Study of Edasalonexent (CAT-1004) in Pediatric Patients With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Los Angeles, CA
Phase 1/2 Study in Boys With Duchenne Muscular Dystrophy
A Phase 1/2 Study of Edasalonexent (CAT-1004) in Pediatric Patients With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials